NTII OTC
Neurobiological Technologies, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -98.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.0001
Volume1,100
Avg Volume1,529
Beta7.38
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJohn B. Stuppin
Employees4
SectorHealthcare
IndustryBiotechnology
IPO Date1994-10-31
2000 Powell Street
EmeryVille, CA 94608
US
EmeryVille, CA 94608
US
510 595 6000
About Neurobiological Technologies, Inc.
Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation and dissolution process, a plan that received stockholder endorsement in October 2009. In its earlier operations, the company's core focus was on the development of experimental pharmaceutical treatments for various human ailments. This firm, which was established in 1987, has its primary location in Emeryville, California.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Firefly Value Partne | P-Purchase | 7,737 | $0.07 | 2010-06-07 |
| Firefly Value Partne | P-Purchase | 12,796 | $0.07 | 2010-06-07 |
| Firefly Value Partne | P-Purchase | 39,940 | $0.07 | 2010-05-21 |
| Firefly Value Partne | P-Purchase | 60,060 | $0.07 | 2010-05-21 |
| Firefly Value Partne | P-Purchase | 11,982 | $0.07 | 2010-05-20 |